Patents by Inventor Arnav Moudgil

Arnav Moudgil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938138
    Abstract: Among the various aspects of the present disclosure is the provision of a methods for increasing chemotherapy sensitivity or decreasing chemotherapy resistance using BET inhibitors.
    Type: Grant
    Filed: July 9, 2021
    Date of Patent: March 26, 2024
    Assignee: Washington University
    Inventors: Robi Mitra, Arnav Moudgil, Michael Nathaniel Wilkinson
  • Publication number: 20220016131
    Abstract: Among the various aspects of the present disclosure is the provision of a methods for increasing chemotherapy sensitivity or decreasing chemotherapy resistance using BET inhibitors.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 20, 2022
    Applicant: Washington University
    Inventors: Robi Mitra, Arnav Moudgil, Michael Nathaniel Wilkinson
  • Publication number: 20200181626
    Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods for mapping transposon insertions. Applications can include mapping the locations of self-reporting transposons (SRTs) from thousands of single cells in parallel, while simultaneously measuring mRNA abundance from the same single cells; analyzing genome-associated protein (GAP) (e.g., transcription factor) binding/interactions in a small number of cells in bulk, without single cell resolution; lineage tracing; or as an improved readout for transposon mutagenesis screens.
    Type: Application
    Filed: December 11, 2019
    Publication date: June 11, 2020
    Applicant: Washington University
    Inventors: Robi D. Mitra, Arnav Moudgil, Michael Nathaniel Wilkinson, Zongtai Qi